Results of the ADVISE II trial presented

A new study supports the use of instantaneous wave-free ratio (iFR), to simplify assessment and determine the severity of coronary artery disease. ADVISE II findings were presented today at the 25th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. Sponsored by the Cardiovascular Research Foundation (CRF), TCT is the world's premier educational meeting specializing in interventional cardiovascular medicine.

Fractional flow reserve (FFR) has consistently been shown to improve patient outcomes when used to decide whether coronary vessels with require revascularization, such as angioplasty or bypass surgery (CABG). However, its use in clinical practice remains low due to the requirement for the use of vasodilator drugs, such as , which can increase procedure time, costs, and patient discomfort.

iFR is a recently introduced pressure-derived index that measures coronary stenosis severity without the requirement for adenosine administration. The role of iFR for lesion assessment vs. FFR has been controversial and hotly debated at recent interventional cardiology meetings.

ADVISE II enrolled 797 patients in a prospective, observational, non-randomized double blind global multi-center registry study with an adaptive design. The diagnostic performance of iFR was analyzed both as a dichotomous index and as part of a hybrid iFR/FFR strategy. iFR was used according to specific cutoffs (iFR zone, ≤0.85 and ≥0.94) with high positive and high negative predictive value for the detection of hemodynamically severe stenosis. FFR use was limited to the "adenosine zone," for iFR values between 0.86 and 0.93. The primary endpoint was the percentage of stenosis properly classified in terms of hemodynamic severity (FFR value ≤ 0.80).

The final study population consisted of 690 stenoses and of these, 31 percent had an associated iFR value in the adenosine zone (0.86-0.93), while 69 percent had associated iFR values in the iFR zone. Within the iFR zone, the percentage of stenosis properly classified in terms of hemodynamic severity was 91.6 percent. Overall the hybrid iFR/FFR approach correctly classified 94.2 percent of coronary stenoses, without the need for adenosine administration in 65.1 percent of patients.

"The results of the ADVISE II study support the use of iFR to simplify physiological guidance of ," said lead investigator Javier Escaned, MD, PhD, and interventional cardiologist from Hospital Clinico San Carlos in Madrid, Spain.

"The promising results demonstrate the potential of boosting the benefits of ischemia-driven revascularization to a larger proportion of patients with ."


Explore further

Results of the ADVISE trial reported at TCT 2011

Citation: Results of the ADVISE II trial presented (2013, October 30) retrieved 21 November 2019 from https://medicalxpress.com/news/2013-10-results-ii-trial.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments